Related Experiment Video
Updated: Sep 9, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Decoding ATXN2 Phosphocode: Structural Insights and Therapeutic Opportunities in Disease
Apoorva Pai Kalasa Anil Kumar1, Suhail Subair1, Prathik Basthikoppa Shivamurthy1
1Yenepoya University, Mangalore, India.
This study maps critical phosphorylation sites on Ataxin-2 (ATXN2), revealing how their regulation impacts RNA metabolism and contributes to neurodegenerative diseases like Spinocerebellar Ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS), as well as cancer.
Area of Science:
- Molecular Biology
- Neuroscience
- Oncology
Background:
- Ataxin-2 (ATXN2) is a crucial RNA-binding protein involved in RNA metabolism, stress granule dynamics, and neuronal health.
- Dysregulated phosphorylation of ATXN2 is implicated in the pathogenesis of Spinocerebellar Ataxia type 2 (SCA2), amyotrophic lateral sclerosis (ALS), and various cancers.
Purpose of the Study:
- To comprehensively map and analyze critical phosphosites within ATXN2's intrinsically disordered regions.
- To elucidate the role of ATXN2 phosphorylation in regulating protein interactions and cellular processes relevant to disease.
- To identify potential therapeutic targets for ATXN2-related disorders.
Main Methods:
- Integration of structural biology, phosphoproteomics, and interactome analyses.
- Identification and characterization of six key ATXN2 phosphosites (S772, T741, S624, S684, S784, S889).
- Analysis of kinase (GSK3β, CDK13) and phosphatase (INPP5F) modulation of these phosphosites.
Main Results:
- Detailed mapping of six critical ATXN2 phosphosites within intrinsically disordered regions.
- Demonstration that these phosphosites modulate interactions with RNA-binding proteins and co-regulated proteins.
- Evidence linking altered ATXN2 phosphorylation to disrupted autophagy, nucleocytoplasmic transport, and stress granule dynamics.
Conclusions:
- Elucidation of the ATXN2 phosphocode provides a mechanistic understanding of its role in neurodegeneration and cancer.
- Targeted therapies, including kinase inhibitors and antisense oligonucleotides, show promise for treating ATXN2-related diseases.
- This research opens new avenues for precision medicine in treating complex diseases involving ATXN2 dysfunction.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Cell Specific Gene Expression
X-Inactivation
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Leaky Scanning

